Uproleselan, Cladribine, and Low Dose Cytarabine for the Treatment of Patients With Treated Secondary Acute Myeloid Leukemia
Clinical trial NCT04848974 · COMPLETED
Trial details
- NCT number
- NCT04848974
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-11
- Primary completion
- 2024-10-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.